APO Research
Talk to an analyst

APO RESEARCH · REPORT

Single-target MET TKIs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Single-target MET TKIs Market Outlook and Growth Opportunities 2026

27 December 2025196 pages

Choose your research edition.

Industry ResearchSingle-target MET TKIs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Single-target MET TKIs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Single-target MET TKIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Single-target MET TKIs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Single-target MET TKIs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Single-target MET TKIs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Single-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Single-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Single-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Single-target MET TKIs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Single-target MET TKIs market include CSPC Pharmaceutical, Asymchem, Shanghai Hutchison Pharmaceuticals, WuXi STA, Haihe Biopharma, Avistone Pharmaceuticals Biotechnology, Novartis and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Single-target MET TKIs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Single-target MET TKIs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Single-target MET TKIs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Single-target MET TKIs market size, projected growth trends, production technologies, key applications, and end-use industries.

Single-target MET TKIs Segment by Company

CSPC Pharmaceutical

Asymchem

Shanghai Hutchison Pharmaceuticals

WuXi STA

Haihe Biopharma

Avistone Pharmaceuticals Biotechnology

Novartis

Merck

Single-target MET TKIs Segment by Type

Tepotinib

Savolitinib

Capmatinib

Glumetinib

Vebreltinib

Other

Single-target MET TKIs Segment by Application

Retail Pharmacies

Hospital and Clinic

Other

Single-target MET TKIs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Single-target MET TKIs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Single-target MET TKIs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Single-target MET TKIs significant trends, drivers, influence factors in global and regions.

6. To analyze Single-target MET TKIs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single-target MET TKIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Single-target MET TKIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single-target MET TKIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Single-target MET TKIs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Single-target MET TKIs industry.

Chapter 3: Detailed analysis of Single-target MET TKIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Single-target MET TKIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Single-target MET TKIs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Single-target MET TKIs Industry Trends Table 2. Single-target MET TKIs Industry Drivers Table 3. Single-target MET TKIs Industry Opportunities and Challenges Table 4. Single-target MET TKIs Industry Restraints Table 5. Global Single-target MET TKIs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Single-target MET TKIs Revenue Share by Company (2021-2026) Table 7. Global Single-target MET TKIs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Single-target MET TKIs Sales Volume Share by Company (2021-2026) Table 9. Global Single-target MET TKIs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Single-target MET TKIs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Single-target MET TKIs Key Company Manufacturing Base & Headquarters Table 12. Global Single-target MET TKIs Company, Product Type & Application Table 13. Global Single-target MET TKIs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Single-target MET TKIs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tepotinib Table 18. Significant Companies of Savolitinib Table 19. Significant Companies of Capmatinib Table 20. Significant Companies of Glumetinib Table 21. Significant Companies of Vebreltinib Table 22. Significant Companies of Other Table 23. Global Single-target MET TKIs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Single-target MET TKIs Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Single-target MET TKIs Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Single-target MET TKIs Sales Volume Share by Type (2021-2026) Table 27. Global Single-target MET TKIs Sales Volume Share by Type (2027-2032) Table 28. Global Single-target MET TKIs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Single-target MET TKIs Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Single-target MET TKIs Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Single-target MET TKIs Sales Value Share by Type (2021-2026) Table 32. Global Single-target MET TKIs Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Retail Pharmacies Table 34. Significant Companies of Hospital and Clinic Table 35. Significant Companies of Other Table 36. Global Single-target MET TKIs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Single-target MET TKIs Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Single-target MET TKIs Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Single-target MET TKIs Sales Volume Share by Application (2021-2026) Table 40. Global Single-target MET TKIs Sales Volume Share by Application (2027-2032) Table 41. Global Single-target MET TKIs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Single-target MET TKIs Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Single-target MET TKIs Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Single-target MET TKIs Sales Value Share by Application (2021-2026) Table 45. Global Single-target MET TKIs Sales Value Share by Application (2027-2032) Table 46. Global Single-target MET TKIs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Single-target MET TKIs Sales by Region (2021-2026) & (K Units) Table 48. Global Single-target MET TKIs Sales Market Share by Region (2021-2026) Table 49. Global Single-target MET TKIs Sales by Region (2027-2032) & (K Units) Table 50. Global Single-target MET TKIs Sales Market Share by Region (2027-2032) Table 51. Global Single-target MET TKIs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Single-target MET TKIs Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Single-target MET TKIs Sales Value Share by Region (2021-2026) Table 54. Global Single-target MET TKIs Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Single-target MET TKIs Sales Value Share by Region (2027-2032) Table 56. Global Single-target MET TKIs Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Single-target MET TKIs Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Single-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Single-target MET TKIs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Single-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 61. Global Single-target MET TKIs Sales Market Share by Country (2021-2026) Table 62. Global Single-target MET TKIs Sales by Country (2027-2032) & (K Units) Table 63. Global Single-target MET TKIs Sales Market Share by Country (2027-2032) Table 64. Global Single-target MET TKIs Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Single-target MET TKIs Sales Value Market Share by Country (2021-2026) Table 66. Global Single-target MET TKIs Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Single-target MET TKIs Sales Value Market Share by Country (2027-2032) Table 68. CSPC Pharmaceutical Company Information Table 69. CSPC Pharmaceutical Business Overview Table 70. CSPC Pharmaceutical Single-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. CSPC Pharmaceutical Single-target MET TKIs Product Portfolio Table 72. CSPC Pharmaceutical Recent Development Table 73. Asymchem Company Information Table 74. Asymchem Business Overview Table 75. Asymchem Single-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Asymchem Single-target MET TKIs Product Portfolio Table 77. Asymchem Recent Development Table 78. Shanghai Hutchison Pharmaceuticals Company Information Table 79. Shanghai Hutchison Pharmaceuticals Business Overview Table 80. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product Portfolio Table 82. Shanghai Hutchison Pharmaceuticals Recent Development Table 83. WuXi STA Company Information Table 84. WuXi STA Business Overview Table 85. WuXi STA Single-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. WuXi STA Single-target MET TKIs Product Portfolio Table 87. WuXi STA Recent Development Table 88. Haihe Biopharma Company Information Table 89. Haihe Biopharma Business Overview Table 90. Haihe Biopharma Single-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Haihe Biopharma Single-target MET TKIs Product Portfolio Table 92. Haihe Biopharma Recent Development Table 93. Avistone Pharmaceuticals Biotechnology Company Information Table 94. Avistone Pharmaceuticals Biotechnology Business Overview Table 95. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product Portfolio Table 97. Avistone Pharmaceuticals Biotechnology Recent Development Table 98. Novartis Company Information Table 99. Novartis Business Overview Table 100. Novartis Single-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Novartis Single-target MET TKIs Product Portfolio Table 102. Novartis Recent Development Table 103. Merck Company Information Table 104. Merck Business Overview Table 105. Merck Single-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Merck Single-target MET TKIs Product Portfolio Table 107. Merck Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Single-target MET TKIs Distributors List Table 111. Single-target MET TKIs Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Single-target MET TKIs Product Image Figure 2. Global Single-target MET TKIs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Single-target MET TKIs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Single-target MET TKIs Sales (2021-2032) & (K Units) Figure 5. Global Single-target MET TKIs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Single-target MET TKIs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tepotinib Image Figure 10. Savolitinib Image Figure 11. Capmatinib Image Figure 12. Glumetinib Image Figure 13. Vebreltinib Image Figure 14. Other Image Figure 15. Global Single-target MET TKIs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Single-target MET TKIs Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Single-target MET TKIs Sales Volume Share by Type (2021-2032) Figure 18. Global Single-target MET TKIs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Single-target MET TKIs Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Single-target MET TKIs Sales Value Share by Type (2021-2032) Figure 21. Retail Pharmacies Image Figure 22. Hospital and Clinic Image Figure 23. Other Image Figure 24. Global Single-target MET TKIs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Single-target MET TKIs Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Single-target MET TKIs Sales Volume Share by Application (2021-2032) Figure 27. Global Single-target MET TKIs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Single-target MET TKIs Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Single-target MET TKIs Sales Value Share by Application (2021-2032) Figure 30. Global Single-target MET TKIs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Single-target MET TKIs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Single-target MET TKIs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Single-target MET TKIs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Single-target MET TKIs Sales Value (2021-2032) & (US$ Million) Figure 35. North America Single-target MET TKIs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Single-target MET TKIs Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Single-target MET TKIs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Single-target MET TKIs Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Single-target MET TKIs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Single-target MET TKIs Sales Value (2021-2032) & (US$ Million) Figure 41. South America Single-target MET TKIs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Single-target MET TKIs Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Single-target MET TKIs Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Single-target MET TKIs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Single-target MET TKIs Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Single-target MET TKIs Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Tepotinib
  • Savolitinib
  • Capmatinib
  • Glumetinib
  • Vebreltinib
  • Other
Applications
  • Retail Pharmacies
  • Hospital and Clinic
  • Other
Companies covered
  • CSPC Pharmaceutical
  • Asymchem
  • Shanghai Hutchison Pharmaceuticals
  • WuXi STA
  • Haihe Biopharma
  • Avistone Pharmaceuticals Biotechnology
  • Novartis
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Single-target MET TKIs Sales Value (2021-2032)
  4. 1.2.2 Global Single-target MET TKIs Sales Volume (2021-2032)
  5. 1.2.3 Global Single-target MET TKIs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Single-target MET TKIs Market Dynamics
  1. 2.1 Single-target MET TKIs Industry Trends
  2. 2.2 Single-target MET TKIs Industry Drivers
  3. 2.3 Single-target MET TKIs Industry Opportunities and Challenges
  4. 2.4 Single-target MET TKIs Industry Restraints
3 Single-target MET TKIs Market by Company
  1. 3.1 Global Single-target MET TKIs Company Revenue Ranking in 2025
  2. 3.2 Global Single-target MET TKIs Revenue by Company (2021-2026)
  3. 3.3 Global Single-target MET TKIs Sales Volume by Company (2021-2026)
  4. 3.4 Global Single-target MET TKIs Average Price by Company (2021-2026)
  5. 3.5 Global Single-target MET TKIs Company Ranking (2024-2026)
  6. 3.6 Global Single-target MET TKIs Company Manufacturing Base and Headquarters
  7. 3.7 Global Single-target MET TKIs Company Product Type and Application
  8. 3.8 Global Single-target MET TKIs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Single-target MET TKIs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Single-target MET TKIs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Single-target MET TKIs Market by Type
  1. 4.1 Single-target MET TKIs Type Introduction
  2. 4.1.1 Tepotinib
  3. 4.1.2 Savolitinib
  4. 4.1.3 Capmatinib
  5. 4.1.4 Glumetinib
  6. 4.1.5 Vebreltinib
  7. 4.1.6 Other
  8. 4.2 Global Single-target MET TKIs Sales Volume by Type
  9. 4.2.1 Global Single-target MET TKIs Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Single-target MET TKIs Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Single-target MET TKIs Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Single-target MET TKIs Sales Value by Type
  13. 4.3.1 Global Single-target MET TKIs Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Single-target MET TKIs Sales Value by Type (2021-2032)
  15. 4.3.3 Global Single-target MET TKIs Sales Value Share by Type (2021-2032)
5 Single-target MET TKIs Market by Application
  1. 5.1 Single-target MET TKIs Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Other
  5. 5.2 Global Single-target MET TKIs Sales Volume by Application
  6. 5.2.1 Global Single-target MET TKIs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Single-target MET TKIs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Single-target MET TKIs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Single-target MET TKIs Sales Value by Application
  10. 5.3.1 Global Single-target MET TKIs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Single-target MET TKIs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Single-target MET TKIs Sales Value Share by Application (2021-2032)
6 Single-target MET TKIs Regional Sales and Value Analysis
  1. 6.1 Global Single-target MET TKIs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Single-target MET TKIs Sales by Region (2021-2032)
  3. 6.2.1 Global Single-target MET TKIs Sales by Region: 2021-2026
  4. 6.2.2 Global Single-target MET TKIs Sales by Region (2027-2032)
  5. 6.3 Global Single-target MET TKIs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Single-target MET TKIs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Single-target MET TKIs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Single-target MET TKIs Sales Value by Region (2027-2032)
  9. 6.5 Global Single-target MET TKIs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Single-target MET TKIs Sales Value (2021-2032)
  12. 6.6.2 North America Single-target MET TKIs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Single-target MET TKIs Sales Value (2021-2032)
  15. 6.7.2 Europe Single-target MET TKIs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Single-target MET TKIs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Single-target MET TKIs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Single-target MET TKIs Sales Value (2021-2032)
  21. 6.9.2 South America Single-target MET TKIs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Single-target MET TKIs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Single-target MET TKIs Sales Value Share by Country, 2025 VS 2032
7 Single-target MET TKIs Country-level Sales and Value Analysis
  1. 7.1 Global Single-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Single-target MET TKIs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Single-target MET TKIs Sales by Country (2021-2032)
  4. 7.3.1 Global Single-target MET TKIs Sales by Country (2021-2026)
  5. 7.3.2 Global Single-target MET TKIs Sales by Country (2027-2032)
  6. 7.4 Global Single-target MET TKIs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Single-target MET TKIs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Single-target MET TKIs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Single-target MET TKIs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Single-target MET TKIs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Single-target MET TKIs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CSPC Pharmaceutical
  2. 8.1.1 CSPC Pharmaceutical Company Information
  3. 8.1.2 CSPC Pharmaceutical Business Overview
  4. 8.1.3 CSPC Pharmaceutical Single-target MET TKIs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CSPC Pharmaceutical Single-target MET TKIs Product Portfolio
  6. 8.1.5 CSPC Pharmaceutical Recent Developments
  7. 8.2 Asymchem
  8. 8.2.1 Asymchem Company Information
  9. 8.2.2 Asymchem Business Overview
  10. 8.2.3 Asymchem Single-target MET TKIs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Asymchem Single-target MET TKIs Product Portfolio
  12. 8.2.5 Asymchem Recent Developments
  13. 8.3 Shanghai Hutchison Pharmaceuticals
  14. 8.3.1 Shanghai Hutchison Pharmaceuticals Company Information
  15. 8.3.2 Shanghai Hutchison Pharmaceuticals Business Overview
  16. 8.3.3 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product Portfolio
  18. 8.3.5 Shanghai Hutchison Pharmaceuticals Recent Developments
  19. 8.4 WuXi STA
  20. 8.4.1 WuXi STA Company Information
  21. 8.4.2 WuXi STA Business Overview
  22. 8.4.3 WuXi STA Single-target MET TKIs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 WuXi STA Single-target MET TKIs Product Portfolio
  24. 8.4.5 WuXi STA Recent Developments
  25. 8.5 Haihe Biopharma
  26. 8.5.1 Haihe Biopharma Company Information
  27. 8.5.2 Haihe Biopharma Business Overview
  28. 8.5.3 Haihe Biopharma Single-target MET TKIs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Haihe Biopharma Single-target MET TKIs Product Portfolio
  30. 8.5.5 Haihe Biopharma Recent Developments
  31. 8.6 Avistone Pharmaceuticals Biotechnology
  32. 8.6.1 Avistone Pharmaceuticals Biotechnology Company Information
  33. 8.6.2 Avistone Pharmaceuticals Biotechnology Business Overview
  34. 8.6.3 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product Portfolio
  36. 8.6.5 Avistone Pharmaceuticals Biotechnology Recent Developments
  37. 8.7 Novartis
  38. 8.7.1 Novartis Company Information
  39. 8.7.2 Novartis Business Overview
  40. 8.7.3 Novartis Single-target MET TKIs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novartis Single-target MET TKIs Product Portfolio
  42. 8.7.5 Novartis Recent Developments
  43. 8.8 Merck
  44. 8.8.1 Merck Company Information
  45. 8.8.2 Merck Business Overview
  46. 8.8.3 Merck Single-target MET TKIs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Merck Single-target MET TKIs Product Portfolio
  48. 8.8.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Single-target MET TKIs Value Chain Analysis
  2. 9.1.1 Single-target MET TKIs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Single-target MET TKIs Sales Mode & Process
  6. 9.2 Single-target MET TKIs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Single-target MET TKIs Distributors
  9. 9.2.3 Single-target MET TKIs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst